Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 1
1986 1
1987 3
1988 3
1989 7
1990 6
1991 12
1992 11
1993 17
1994 17
1995 12
1996 14
1997 7
1998 14
1999 8
2000 20
2001 15
2002 5
2003 11
2004 7
2005 5
2006 4
2007 5
2008 5
2009 3
2010 5
2011 4
2012 3
2013 6
2014 3
2015 2
2016 2
2017 3
2018 3
2020 2
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
High-dose etoposide and marrow transplantation.
Herzig RH. Herzig RH. Cancer. 1991 Jan 1;67(1 Suppl):292-8. doi: 10.1002/1097-0142(19910101)67:1+<292::aid-cncr2820671314>3.0.co;2-7. Cancer. 1991. PMID: 1984830 Review.
When etoposide was used as a single agent in these high-dose trials, mucositis, and, to a lesser degree, hepatic dysfunction were dose-limiting. The maximum tolerated dose (MTD) in this setting was 2.4 to 3.0 g/m2. Multi-agent Phase I trials with etoposide …
When etoposide was used as a single agent in these high-dose trials, mucositis, and, to a lesser degree, hepatic dysfun …
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies.
Blume KG, Forman SJ, O'Donnell MR, Doroshow JH, Krance RA, Nademanee AP, Snyder DS, Schmidt GM, Fahey JL, Metter GE, et al. Blume KG, et al. Blood. 1987 Apr;69(4):1015-20. Blood. 1987. PMID: 3548841 Free article.
In a phase I/II study, 47 patients (median age, 24 years) with hematologic malignancies (33 patients with acute leukemia not in first remission and 14 patients with other advanced malignant hematologic disorders) were treated with total body irradiation and h …
In a phase I/II study, 47 patients (median age, 24 years) with hematologic malignancies (33 patients with acute leukemia not in first remiss …
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.
Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Negrin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS, et al. Snyder DS, et al. Blood. 1993 Nov 1;82(9):2920-8. Blood. 1993. PMID: 8219241 Free article.
Ninety-nine consecutive patients with acute leukemia in first complete remission under age 50 (median age 27 years; age range 1 to 47 years) with a histocompatible sibling donor were treated with fractionated total body irradiation (1,320 cGy) and high …
Ninety-nine consecutive patients with acute leukemia in first complete remission under age 50 (median age 27 years; age range 1 to 47 years) …
High-dose etoposide in allogeneic stem cell transplantation.
Bruserud O, Reikvam H, Kittang AO, Ahmed AB, Tvedt TH, Sjo M, Hatfield KJ. Bruserud O, et al. Cancer Chemother Pharmacol. 2012 Dec;70(6):765-82. doi: 10.1007/s00280-012-1990-z. Epub 2012 Oct 6. Cancer Chemother Pharmacol. 2012. PMID: 23053272 Review.
The anti-leukemic effect of etoposide is well documented. High-dose etoposide 60 mg/kg in combination with fractionated total body irradiation (TBI), usually single fractions of 1.2 Gy up to a total of 13.2 Gy, is used as co …
The anti-leukemic effect of etoposide is well documented. High-dose etoposide 60 mg/kg in combination with fract …
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group.
Brown RA, Wolff SN, Fay JW, Pineiro L, Collins RH Jr, Lynch JP, Stevens D, Greer J, Herzig RH, Herzig GP. Brown RA, et al. Blood. 1995 Mar 1;85(5):1391-5. Blood. 1995. PMID: 7858269 Free article. Clinical Trial.
To reduce the risk of relapse following BMT for patients with hematologic malignancy, our group developed a novel preparative regimen which combines high-dose etoposide with cyclophosphamide and total body irradiation (VPCyTBI). ...
To reduce the risk of relapse following BMT for patients with hematologic malignancy, our group developed a novel preparative regimen which …
Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases.
Burdach S, Thiel U, Schöniger M, Haase R, Wawer A, Nathrath M, Kabisch H, Urban C, Laws HJ, Dirksen U, Steinborn M, Dunst J, Jürgens H; Meta-EICESS Study Group. Burdach S, et al. Bone Marrow Transplant. 2010 Mar;45(3):483-9. doi: 10.1038/bmt.2009.184. Epub 2009 Aug 17. Bone Marrow Transplant. 2010. PMID: 19684633 Clinical Trial.
We examined the role of total body magnetic resonance imaging (TB-MRI)-governed involved compartment irradiation (ICI) and high-dose chemotherapy (HDC), followed by stem cell rescue (SCR) in patients with high-risk Ewing tumors (ETs) with multip …
We examined the role of total body magnetic resonance imaging (TB-MRI)-governed involved compartment irradiation (ICI) …
Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL. Wu DP, et al. Bone Marrow Transplant. 1994 Nov;14(5):751-7. Bone Marrow Transplant. 1994. PMID: 7889008
Eleven patients with acute myeloblastic leukemia (AML) beyond the first complete remission or chronic myelogenous leukemia (CML) not in first chronic phase received an association of 13.5 Gy of fractionated total body irradiation (TBI) followed by cyclophosph …
Eleven patients with acute myeloblastic leukemia (AML) beyond the first complete remission or chronic myelogenous leukemia (CML) not in firs …
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma.
Tseng YD, Stevenson PA, Cassaday RD, Cowan A, Till BG, Shadman M, Graf SA, Ermoian R, Smith SD, Holmberg LA, Press OW, Gopal AK. Tseng YD, et al. Biol Blood Marrow Transplant. 2018 Feb;24(2):282-287. doi: 10.1016/j.bbmt.2017.10.029. Epub 2017 Oct 20. Biol Blood Marrow Transplant. 2018. PMID: 29061536 Free article.
Autologous stem cell transplant (ASCT) consolidation has become a standard approach for patients with mantle cell lymphoma (MCL), yet there is little consensus on the role of total body irradiation (TBI) as part of high-dose transplantation cond …
Autologous stem cell transplant (ASCT) consolidation has become a standard approach for patients with mantle cell lymphoma (MCL), yet there …
Unexpected acute renal injury after high-dose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation.
Cordero C, Loboda C, Clerc-Urmès I, Clément L, Pochon C, Chastagner P. Cordero C, et al. Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26669. Epub 2017 Jul 11. Pediatr Blood Cancer. 2017. PMID: 28696051
High-dose etoposide phosphate, a water-soluble prodrug of etoposide, may be used after total body irradiation (TBI) in pediatric allogeneic bone marrow transplantation for lymphoblastic leukemia. ...No risk factors were identified. …
High-dose etoposide phosphate, a water-soluble prodrug of etoposide, may be used after total body …
241 results